RxDoctor Payments Data

Paige Himes

Medical · Mount Union, PANPI 1144758327

Payments from drug & device makers

$3,163in general payments, 2019–2025

Across 193 payments — averaging $16.39 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$523
  • GSK$454
  • Lilly USA, LLC$415
  • AstraZeneca$251
  • Pfizer$251
  • Astellas Pharma US Inc$241
  • plus $1K from 19 others

What the payments were for

  • Food & beverage$3,163100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$3,163 in reported general payments places this provider in the 85th percentile of 2,594 medical providers in Pennsylvania.

See all medical providers in Pennsylvania

Most prescribed under Part D

DrugClaimsCost to plans & patients
JardianceEmpagliflozin113$82,761
RybelsusSemaglutide79$76,877
JanuviaSitagliptin Phosphate69$53,312
EliquisApixaban55$41,757
TrulicityDulaglutide29$40,157
Trelegy ElliptaFluticasone/Umeclidin/Vilanter40$36,964
OzempicSemaglutide40$36,419
MounjaroTirzepatide21$26,108
Anoro ElliptaUmeclidinium Brm/Vilanterol Tr35$16,398
Toujeo SolostarInsulin Glargine,hum.Rec.Anlog20$16,122
Breztri AerosphereBudesonide/Glycopyr/Formoterol19$14,667
MyrbetriqMirabegron19$8,899
XareltoRivaroxaban13$7,686
VascepaIcosapent Ethyl20$6,945
GlyxambiEmpagliflozin/Linagliptin12$6,486

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Novo NordiskRybelsus, Ozempic$523$113,296119 claims
Boehringer IngelheimJardiance, Glyxambi, Combivent Respimat$89$94,481136 claims
Lilly USA, LLCTrulicity, Mounjaro$415$66,26550 claims
GSKTrelegy Ellipta, Anoro Ellipta$454$53,36275 claims
MerckJanuvia$15$53,31269 claims
PfizerEliquis$251$41,75755 claims
AstraZenecaBreztri Aerosphere$251$14,66719 claims
Astellas Pharma US IncMyrbetriq$241$8,89919 claims
Johnson & JohnsonXarelto$12$7,68613 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,594 medical providers in Pennsylvania.

Other medical in Mount Union

See the full list for Pennsylvania

Where these figures come from

Is this you, or does something look wrong? →